Colgate-Palmolive (India) Ltd
NSE: COLPAL BSE: 500830FMCG
Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.[1]
₹2,140
52W: ₹1782 — ₹2747
PE 43.6 · Book ₹58.2 · +3577% vs bookMarket Cap₹58,218 Cr
Stock P/E43.6Price to Earnings
ROCE105%Return on Capital
ROE81.2%Return on Equity
Div. Yield2.37%Face Value ₹1
Strengths
- +Company is almost debt free.
- +Company has a good return on equity (ROE) track record: 3 Years ROE 72.4%
- +Company has been maintaining a healthy dividend payout of 106%
Weaknesses
- −Stock is trading at 36.7 times its book value
- −The company has delivered a poor sales growth of 5.95% over past five years.
Shareholding Pattern
Promoters51%
FIIs13.6%
DIIs15.25%
Public19.87%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% |
| FIIs | 24.44% | 24.94%▲0.5 | 23.72%▼1.2 | 22.23%▼1.5 | 20.39%▼1.8 | 17.16%▼3.2 | 15.18%▼2.0 | 13.6%▼1.6 |
| DIIs | 5.72% | 5.55%▼0.2 | 6.57%▲1.0 | 7.84%▲1.3 | 9.34%▲1.5 | 11.95%▲2.6 | 13.5%▲1.6 | 15.25%▲1.8 |
| Public | 18.54% | 18.22%▼0.3 | 18.44%▲0.2 | 18.65%▲0.2 | 19%▲0.4 | 19.59%▲0.6 | 20.03%▲0.4 | 19.87%▼0.2 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,471 | 1,396 | 1,490 | 1,497 | 1,619 | 1,462 | 1,463 | 1,434 | 1,520 | 1,486 |
| Expenses | 989 | 927 | 958 | 988 | 1,122 | 1,007 | 964 | 981 | 1,054 | 1,044 |
| Operating Profit | 482 | 468 | 532 | 508 | 497 | 454 | 498 | 453 | 465 | 442 |
| OPM % | 33% | 34% | 36% | 34% | 31% | 31% | 34% | 32% | 31% | 30% |
| Net Profit | 340 | 330 | 380 | 364 | 395 | 323 | 355 | 321 | 328 | 324 |
| EPS ₹ | 12.5 | 12.14 | 13.96 | 13.38 | 14.52 | 11.87 | 13.05 | 11.79 | 12.04 | 11.91 |
AI Insights
Revenue Trend
TTM revenue at ₹5,902Cr, down 2.3% YoY. OPM at 31%.
Debt Position
Borrowings at ₹60Cr. Debt-to-equity ratio: 0.04x. Healthy balance sheet.
Capex Cycle
CWIP at ₹29Cr (4% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 15.25% (+7.73pp change). FIIs: 13.6% (-8.20pp change). Promoters hold 51%.
Margin & Efficiency
ROCE declining from 122% (Mar 2014) to 105% (Mar 2025). Working capital days: -37.
Valuation
PE 43.6x with 105% ROCE. Price is 3577% above book value of ₹58.2. Dividend yield: 2.37%.
Recent Announcements
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 13 May
- Board Meeting Intimation for Approval Of Audited Financial Results And Declaration Of Interim Dividend. 11 May - Board meets May 22, 2026 to approve audited FY26 results and consider dividend.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Apr - Please find herewith attached Newspaper Publication.
- Announcement under Regulation 30 (LODR)-Press Release / Media Release 8 Apr - Colgate launches free dental check-ups via QR code, 63,000 dentists, and virtual consultations across India.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Please find herewith attached Confirmation Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse